Tengion Email Format

BiotechnologyPennsylvania, United States51-200 Employees

Tengion is a clinical-stage biotechnology company based in East Norriton, Pennsylvania, focused on regenerative medicine that leverages the body's intrinsic healing pathways to form native-like organs and tissues. Its Organ Regeneration Platform aims to create product candidates that can reduce or replace the need for donor organs or anti-rejection therapies, targeting conditions where tissue or organ regeneration could improve patient outcomes. The company’s lead clinical program is the Neo-Urinary Conduit, an autologous implant designed to stimulate bladder tissue regeneration for patients requiring urinary diversion after bladder removal, while its Neo-Kidney Augment preclinical program seeks to delay or prevent the need for dialysis or transplantation in those at risk of kidney failure. Tengion is actively pursuing multiple clinical paths, including Phase II trials for Neo-Bladder Augment to treat neurogenic bladder, and holds worldwide rights to its product candidates. The organization operates within the biotechnology research sector, positioning itself as a developer of regenerative solutions intended to address organ and tissue regeneration needs in clinical care.

Sign up for free to view info

Company overview Employee directory